Clinical Case Reports (Feb 2022)

Laryngitis after inhalation of liposomal amikacin

  • Atsuho Morita,
  • Ho Namkoong,
  • Makoto Hosoya,
  • Naoki Hasegawa

DOI
https://doi.org/10.1002/ccr3.5350
Journal volume & issue
Vol. 10, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract A 56‐year‐old woman with pulmonary Mycobacterium avium complex disease was started on inhalation liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after treatment discontinuation, and no recurrence occurred even after resuming intermittent inhalation.

Keywords